Simple urine test could spot bladder cancer before it spreads

NCT ID NCT05347342

Ongoing Diagnosis Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new urine test to detect bladder cancer early in people at high risk, such as smokers over 50. Researchers will check how accurate the test is and use the data to build a risk calculator. The goal is to offer a non-invasive way to catch the disease sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive urine test to catch bladder cancer early in people at high risk.
What could go wrong: This is an early-stage study with 173 participants, so results may not apply to everyone. The test may not be accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States
Long Beach VA Healthcare System

Long Beach, California, 90712, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.